ArticleFukushima journal of medical science2026
Changes in phosphoethanolamine during the postpartum period and its association with depression.
Article in Fukushima journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to examine phosphoethanolamine (PEA) in postpartum women and its association with postpartum depression (PPD).
methodsThis prospective study, performed between July 2020 and August 2021 at Fukushima Medical University Hospital, included 67 women. They answered two questionnaires, the Edinburgh Postpartum Depression Scale (EPDS) and the Patient Health Questionnaire-9 (PHQ-9). EPDS is the screening tool for PPD, and the PHQ-9 scores can evaluate the degree of depressive symptom severity. Blood was collected at 5 and 40 days postpartum, and PEA levels were measured.
resultsThe PEA levels of all postpartum women on day 5 were significantly lower than those on day 40. EPDS and PHQ-9 scores were significantly lower on day 40 than those on day 5 postpartum. No significant correlation was observed between the PPD-suspected (EPDS≥9) women and PEA levels, and no significant correlation was found between plasma PEA levels and PHQ-9 scores on postpartum days 5 and 40.
conclusionsThis study found that PEA levels on postpartum day 5 were lower than on postpartum day 40. It also suggested that there was no association between the degree of postpartum depression and plasma PEA concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.